Created at	Source	Raw Value	Validated value
June 25, 2024, noon	usa	* severe covid-19 patients (ameriten sent immediately to second level of care, hospital) patients with any personal pathological history of hematological diseases. • patients allergic to macrolides (azithromycin) and ivermectin.	* severe covid-19 patients (ameriten sent immediately to second level of care, hospital) patients with any personal pathological history of hematological diseases. • patients allergic to macrolides (azithromycin) and ivermectin.
Dec. 19, 2020, 12:31 a.m.	usa	- severe covid-19 patients (ameriten sent immediately to second level of care, hospital) patients with any personal pathological history of hematological diseases. • patients allergic to macrolides (azithromycin) and ivermectin.	- severe covid-19 patients (ameriten sent immediately to second level of care, hospital) patients with any personal pathological history of hematological diseases. • patients allergic to macrolides (azithromycin) and ivermectin.